Shoulder Surgery for Rotator Cuff Tears
(SCR Trial)
Trial Summary
What is the purpose of this trial?
To compare bridging reconstruction to superior capsular reconstruction using human dermal allograft augmentation for repair of massive rotator cuff tears.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Bridging Rotator Cuff Reconstruction, GRAFTJACKET™ allograft, Superior Capsular Reconstruction, Arthroscopic Superior Capsular Reconstruction, SCR?
Research shows that superior capsular reconstruction (SCR) is a promising treatment for large rotator cuff tears, with studies indicating that different graft types, including acellular dermal allografts, can improve shoulder function and reduce pain. These grafts have shown similar outcomes and complication rates, suggesting they are effective for patients with irreparable rotator cuff tears.12345
Is shoulder surgery for rotator cuff tears generally safe?
The research on superior capsular reconstruction (SCR) for rotator cuff tears suggests it is generally safe, with studies focusing on its effectiveness and complication profile. While specific safety data is not detailed, the procedure is commonly used and studied, indicating a level of safety in humans.26789
How is the treatment GRAFTJACKET™ allograft, Superior Capsular Reconstruction different from other treatments for rotator cuff tears?
Superior Capsular Reconstruction (SCR) with GRAFTJACKET™ allograft is unique because it uses a dermal allograft to restore shoulder joint stability and improve function in patients with massive, irreparable rotator cuff tears, especially in active individuals. This treatment is particularly beneficial for those who are not ideal candidates for more invasive procedures like reverse total shoulder arthroplasty.1581011
Research Team
Ivan Wong, MD
Principal Investigator
Nova Scotia Health Authority
Eligibility Criteria
This trial is for individuals with a confirmed MRI diagnosis of large or massive rotator cuff tears involving two tendons in the shoulder. Candidates should not have severe shoulder issues, uncontrolled diabetes, infections, cancer, or be pregnant. A good nutritional state and no paralysis or contracture of the affected shoulder are required.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative
Routine radiographs and pre-operative MRI are obtained; informed consent process
Surgical Treatment
Patients undergo either bridging reconstruction or superior capsular reconstruction
Postoperative Immobilization
Shoulder immobilized in a sling; passive motion allowed
Rehabilitation
Progression to active shoulder motion and strengthening
Follow-up
Regular follow-up appointments for clinical examination and imaging
Treatment Details
Interventions
- Bridging Rotator Cuff Reconstruction
- GRAFTJACKET™ allograft
- Superior Capsular Reconstruction
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nova Scotia Health Authority
Lead Sponsor